Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

Saved in:
Bibliographic Details
Title: Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.
Authors: Hinterleitner C; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Barthet VJA; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Goldberg HV; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10065, USA., Vogt KC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Perea AM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Cancer Engineering Program, Gerstner Sloan Kettering School for Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ruiz S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10065, USA., Hillger LR; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., McHugh D; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ho YJ; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chaves-Perez A; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Skamagki M; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Flowers S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Zhuang X; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Barretto GD; Flow Cytometry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065 USA., Li X; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Watson JT; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Luan W; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Simon J; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Tammela T; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Gardner R; Flow Cytometry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065 USA., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10065, USA., Romesser PB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Bott MJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA., Filliol A; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Heller DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10065, USA., Lowe SW; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Mar 04. Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.03.02.706451